Migraine Canada Logo
MIGRAINE MODE

Welcome to an insightful discussion on acute and abortive treatments for migraine, presented by Dr. Alex Melanishin, a distinguished neurologist and headache specialist based in London, Ontario. In this session, we explore essential medications tailored for managing migraine attacks as needed, from traditional options to innovative approaches gaining popularity across borders. Dr. Melanishin draws from extensive clinical experience and ongoing research in the field, highlighting both established treatments like NSAIDs and triptans, as well as emerging therapies such as gepants and beta blocker eye drops. Join us as we navigate the complexities of choosing the right acute treatment, considerations for special populations, and the evolving landscape of migraine care. Whether you’re new to migraine management or seeking advanced insights, this webinar promises valuable perspectives and practical guidance for optimizing treatment outcomes.

Click Here to View Transcript

0:00 so I want to thank you Alex and also
0:02 Mike and Canada for inviting me tonight
0:03 to give you this chat about acute and
0:06 abortive treatment options
0:07 and so just as a quick overview for
0:09 those who are kind of new to the
0:10 migraine world we kind of think broadly
0:13 of medications for migraine and two main
0:15 Strokes you’ve either got preventive
0:17 options which are what you take every
0:18 day to try to Stave off a headache or
0:20 you’ve got acute or a board of lunch
0:22 which are the ones you might take as PRN
0:24 or on an as needed basis so we’re going
0:26 to focus on the as needed medicines and
0:28 everybody knows the common stuff but I
0:30 have some kind of unusual ones that I’ve
0:32 been collecting from my friends abroad
0:34 so it’s nice to just kind of get an idea
0:36 of some other ones you might be able to
0:37 try
0:40 so
0:43 I think it’s just Frozen so my name is
0:46 Alex melanishin I’m a neurologist and a
0:48 headache specialist and I run a headache
0:50 medicine practice in London Ontario so
0:52 I’d say about 95 of my uh practices
0:55 dedicated to headache with a little bit
0:56 of epilepsy brain tumors Ms that kind of
0:59 thing
0:59 um but I’m very interested about
1:01 migraine because it runs deeply in my
1:03 family and you know my other interests
1:05 within the headache World extend to
1:07 things like cluster headache psilocybin
1:09 and cannabinoid research so it’s a very
1:12 exciting time for for headache because
1:13 we have all these new treatments after
1:15 having Decades of relative quiet you
1:17 know on the on the medication front so
1:19 I’m happy to kind of share these new
1:21 updates with you
1:26 for disclosures just you’re aware I do
1:29 work with a lot of these drug companies
1:31 as they start to develop and analyze
1:33 their data and and kind of share it to
1:35 the market uh and so I’m often
1:38 participating in advisory boards for
1:40 companies like Novartis really Teva
1:42 linback and happy as well as like if
1:44 speaker uh talks to various groups
1:47 whether it’s pharmacists nurse
1:48 practitioners family doctors other
1:50 neurologists you know I try to spread
1:52 the gospel about migraine to make sure
1:53 as many of us are on the same page
1:56 trying to help other people with
1:57 headache
1:59 so for tonight what we’re going to talk
2:01 about is picking a migraine abortive
2:03 we’re also going to cover some of the
2:06 special considerations for groups of
2:07 people that traditionally don’t have a
2:09 lot of options this would be the elderly
2:11 you know technically people over 65
2:13 although for neurology I think 85 Plus
2:15 is ugly for me and the pregnant and
2:19 those who have cardiovascular risk
2:20 factors whether that’s you know vascular
2:22 disease and Gina hypertension
2:24 cholesterol diabetes when you have
2:27 enough of them we start to get a little
2:28 bit uh concerned about some of the
2:30 medicines
2:31 for acute treatments we’re going to
2:32 cover NSAIDs and tryptins I think most
2:35 people with migraine are familiar of the
2:36 two main categories we would consider
2:38 suvex and cambia are kind of new
2:42 versions of old friends that are
2:43 formulated in a much better way and may
2:45 provide you some extra benefit if you
2:47 haven’t had the chance to try them yet
2:50 one option that’s gaining a lot of
2:51 popularity especially South of the
2:53 Border is timel eye drops these are a
2:55 beta blocker eye drop that you can use
2:57 in an acute fashion and it’s a really
2:59 interesting option for those who fail to
3:01 respond to Conventional things or can’t
3:03 take those medications for whatever
3:05 reason
3:06 and then I want to introduce you to a
3:08 new class of medications called the G
3:10 pants if you’ve been going through the
3:11 migraine Canada Farms you’re probably
3:13 already familiar with them and their
3:15 imminent release here in Canada
3:17 um but they’re very interesting because
3:19 they’re similar to the cgrp antibodies
3:22 you may have heard about but depending
3:24 on which one it can be used as a
3:25 preventive or as an acute medication so
3:27 it’s really changing the way we think
3:29 about our medicines for migraine
3:32 another disclaimer here is that some of
3:34 the information included in this
3:35 presentation it references products
3:37 which are approved in the states under
3:39 FDA but have yet to be officially
3:41 approved by Health Canada so until we
3:44 get that official last seal you know we
3:45 have to warn you that the safety and
3:47 efficacy of these products is not
3:48 established and still being investigated
3:51 so if we’re coming across something
3:52 unusual like this mostly the gpants in
3:54 this case you’re going to see a little
3:55 Caution sign that I stuck in the corner
3:59 so I wanted to show you our Canadian
4:01 Headache Society guidelines for acute
4:03 treatment these are dating back a while
4:05 now 2013 which is like back when I
4:08 graduated from medical school so you
4:10 know they’re a little bit out of date
4:11 now and I know Suzanne Christie is
4:13 working very hard with her group in
4:15 Ottawa to update both the acute and
4:16 preventive guidelines
4:18 um so the problem is every time you turn
4:20 around we’ve got a couple new options
4:21 coming up so it’s constantly taking
4:24 updating
4:25 in this I just wanted to highlight some
4:27 of the more popular options that you can
4:30 consider I would say like we talked
4:32 about the Mainstays are two main
4:33 categories the NSAIDs and the triptans
4:37 of the trip dance I would say probably
4:39 the best bang for your buck from a money
4:41 perspective and efficacy is going to be
4:44 something like rhizotryption sumatriptan
4:46 or allatryptin and every doctor kind of
4:49 has their own Voodoo about how they
4:50 select them the triptans are a bit of a
4:52 rainbow you know there’s about seven of
4:54 them they all have slightly different
4:56 pharmacokinetics which means they may
4:57 take different amounts of time to peek
4:59 in your blood to absorb them uh to
5:02 linger in the blood for a while and some
5:04 of them can be taken as a pill orally as
5:07 a nasal spray or as a needle so
5:09 depending on which one you’re using they
5:10 have slightly different profiles
5:13 um the NSAIDs on the other hand I would
5:15 say the Mainstay of this one is naproxen
5:16 and it’s the cheap old medicine and it’s
5:19 cost effective it works very well
5:21 diclofenac is another cousin a
5:24 non-steroidal anti-inflammatory and this
5:26 one if it’s done in the right
5:27 preparation of the potassium salt in an
5:29 effervescent form is actually the
5:31 fastest you know instead of action and
5:33 and we’ll cover that in a second just to
5:35 be aware of the contraindications we’ll
5:36 go more into depth in these in the
5:38 future but for trip dance anybody who
5:41 had a history of coronary artery disease
5:42 stroke mini stroke heart attack angina
5:45 any kind of blood vessel disease
5:47 including raynauds uh you know you
5:49 really were contraindicated from taking
5:51 this they’re excluded from the trials
5:52 and because they constrict blood vessels
5:55 the thinking is like this might uh
5:57 produce you know vasoconstriction in a
5:59 ischemic event in people who are
6:01 vulnerable
6:02 um in pregnancy they’re considered
6:04 category C which is kind of like an
6:06 unknown kind of gray status but I’ll
6:09 give you some pearls later on that maybe
6:12 would suggest it’s probably safer to use
6:13 in this context
6:15 so
6:16 you might want to take a screenshot of
6:18 this one these are my favorite acute
6:19 medications and like I mentioned every
6:21 doctor kind of has their own bag of
6:22 tricks for NSAIDs I usually start with
6:24 the cheap stuff naproxen 500. you can
6:27 take it as a leave over the counter but
6:29 this is only 220 milligrams
6:31 I would say it can be safely used by
6:33 most people 500 milligrams up to twice a
6:35 day no more than 15 days per month and
6:38 that really is the upper limit of that
6:40 medication over your headache beyond
6:42 that you’re going to run the risk of
6:43 developing kind of a rebound or or
6:46 withdrawal type headache which we call
6:48 medication ovaries headache
6:50 for those people who say well you know I
6:52 really get terrible dyspepsia I can’t
6:54 handle advocacy
6:55 I tend to offer them their view matone
6:58 instead and this was a pearl given to me
7:00 by some of my mentors over at women’s
7:02 college and nabilitone is like the ugly
7:05 sister of the NSAID family for some
7:06 reason she didn’t get publicized well
7:09 and didn’t get a good shake from from
7:11 the advertisements it’s a lot slower to
7:14 Peak but it does linger longer in the
7:17 blood and it doesn’t cause as much
7:18 gastric irritation so I’ve had really
7:20 good success with those patients who
7:21 tend to be very sensitive in the stomach
7:23 so you can ask your doctor for that if
7:25 that seems to be the case for you
7:28 the one I’d like to highlight today is
7:30 tambia which you may have tried it comes
7:33 in a little white uh paper metal fashion
7:35 and you mix it into two ounces of water
7:38 and Stir It Up it is the fastest onset
7:40 of action but because it’s about you
7:42 know 10 bucks or so per dose it can be
7:44 out of the reach for some
7:46 for the trip cans my favorite are
7:48 rhizotryptin which is somewhere in the
7:49 middle of that Spectrum we’re talking
7:50 about and for those who find it isn’t
7:53 strong enough I tend to work it in a
7:54 stepwise fashion we’ll jump up to
7:56 sumatriptan which is the eldest and
7:58 sometimes the strongest but you know the
8:00 balance of that is it may have a little
8:01 bit more side effects chest tightness
8:03 tingling a bit of drowsiness
8:05 for those who find rides are tripped and
8:07 too strong I’ll drop down to things like
8:09 Elmo or Nara tripton which are ones that
8:11 we often use in children and tend to be
8:13 even better tolerated
8:15 the other Pearl that I think you know we
8:17 always tell people treat early
8:19 um but I think some patients
8:21 misinterpret this that if the headache
8:23 is already Brewing it’s too late and I
8:25 shouldn’t even bother taking my tripping
8:26 that’s not true tryptans are useful at
8:29 any stage of the migraine but the chance
8:31 of it working and nipping it in about
8:32 100 very quickly kind of falls off and
8:35 the best chance to treat it is either
8:37 during the aura or very early on in the
8:38 outset so treat early is the first Pearl
8:41 the second one is combining the NSAID
8:44 and the trip stem
8:45 and so there are certain formulations
8:47 you can buy like suvex where this has
8:49 already done for you or you can actually
8:51 take the separate prescriptions and put
8:52 them together
8:53 what I emphasize for my patients is that
8:56 the Gestalt or the sum of the parts is
8:59 greater than each individual and so one
9:02 plus one equals three kind of thing so
9:04 there’s a lot of synergy between these
9:06 medicines they help each other absorb
9:07 more rapidly and peak in the serum and
9:10 so taking it together understandably
9:12 many people want to take as little
9:13 medicine as possible but it should be
9:15 kept as a tool if you really aren’t
9:17 doing well with each agent alone
9:20 so don’t forget your acute medications
9:22 sometimes in a rush doctors just focus
9:25 on the prevention and if you suffer with
9:28 a migraine I would say if there are no
9:29 other contraindications to taking it you
9:32 should definitely try a trip tent it is
9:34 a specific medication for migraine and
9:36 if you’re on the fence then they say
9:38 probable migraine or maybe it’s a
9:39 migraine we don’t really know if it
9:41 responds well to a trip then that pretty
9:42 much clinches the diagnosis
9:45 contraindications include like I said
9:47 coronary artery disease which includes
9:49 Mi or you know angina a history of
9:52 stroke or mini strokes vascular disease
9:54 uncontrolled high blood pressure and
9:56 also Reynolds phenomenon this is another
9:59 thing that many people believe they have
10:01 Reynolds
10:02 when in fact they just have poor
10:03 circulation and we live in Canada and
10:05 they’re not wearing gloves so I will
10:07 actually sit down with patients and show
10:09 them all the pictures on Google
10:10 of Reynolds Phenomenon with the you know
10:12 digital power which is the areas of
10:14 white uh digits on the knuckles and
10:16 things like that uh the libido
10:18 reticularis and everything associated
10:19 with Reynolds and they’ll say well
10:22 actually no I don’t have that at all my
10:23 fingers just go a little bit pale and
10:25 cold and so I think that’s the
10:26 difference
10:27 if there’s any question at all and you
10:29 think you may have an inflammatory
10:30 tissue or autoimmune disorder and you
10:33 think you have Reynolds I would say it’s
10:35 worth a shot to go see the
10:36 rheumatologist and have them confirm it
10:37 for you
10:39 um you may need to try more than one
10:41 trip then before you find the one that
10:42 fits you and this is kind of unusual
10:45 because we think of the chemistry of
10:46 them as all being relatively similar and
10:48 comparable but that’s not the case
10:51 um you know they all have different
10:52 pharmacokinetics and sometimes it really
10:54 does take a trial of a few of them to
10:56 find one that that you tolerate very
10:58 well and that works very well for you
11:00 we talked about treating it early
11:02 the other point is that you can take a
11:04 second dose so some people don’t always
11:06 follow up quick enough sometime within
11:08 two to four hours if you’re not feeling
11:10 any better or you think you can do
11:11 better you can repeat a second dose both
11:14 of your trip 10 and of your handset
11:18 um the limits for the medication ovary
11:19 is headache I hammer home with my
11:20 patients every time we talk and meet
11:22 together they know I’m kind of clogging
11:24 a horse here uh that doesn’t require it
11:26 but it’s fewer than 15 days monthly for
11:28 the simple stuff and that’s you know
11:30 Advil Tylenol naproxen
11:32 um your your NSAIDs
11:34 for the harder things and this includes
11:36 categories like oh which personally I
11:40 avoided in my practice unless you’re
11:42 you’re palliative for a brain tumor or
11:44 really you can’t take any other medicine
11:46 uh tryptens butalbital containing
11:49 compounds which is like the ancient
11:50 Journal that we’re all trying to get
11:51 everybody off of these ones really have
11:54 to be used with caution the official
11:56 limit is 10 days per month but some
11:58 studies show that butalbital and opioid
12:00 containing compounds as little as three
12:02 to six days per month May toss them into
12:04 overuse headache
12:05 so let’s start with cambia
12:08 um like I mentioned this diclofenac
12:10 potassium it’s a fine powder you mix it
12:12 into you know two ounces of water which
12:15 is a really tiny amount and it’s kind of
12:17 nice because you can knock it back
12:18 quickly and it’s not everybody’s
12:19 favorite flavor uh it’s a combination of
12:22 mint and anise to mask the bitterness of
12:24 the medicine
12:25 um and you know so some people love it
12:27 other people not so much and uh the good
12:31 news is that it is very effective as an
12:32 abortive and so it Peaks within the
12:35 blood within 15 minutes and has very
12:37 rapid absorption doesn’t seem to matter
12:39 uh whether you take it with food or not
12:42 and I want to show you a graph here to
12:44 compare the diclofenac tablet the exact
12:47 same medicine and sometimes the
12:49 pharmacist will say oh don’t worry a
12:51 cheap version is you can get a tablet
12:52 and grind it up and and mix it with
12:54 water and it does the same thing that is
12:56 not true it is not a potassium salt and
12:59 so the potassium and sodium cells are
13:00 absorbed differentially and also this is
13:03 a special effervescent preparation that
13:05 facilitates that absorption so I would
13:08 caution that it really is not the same
13:09 thing and that really can be on this
13:12 instance is superior
13:13 so we get measurable plasma levels in
13:15 five minutes Peak plasma levels in 15
13:18 minutes food does not absorb the time to
13:21 maximum serum levels and just to show
13:25 you kind of the relative comparison to
13:26 the cousins can be as peaking there
13:29 somewhere around 15 minutes while your
13:31 other NSAIDs like ibuprofen and naproxen
13:33 are taking uh you know an hour and
13:35 Beyond to get up to those levels
13:39 for a comparison between cambia and the
13:41 dense things like sumatriptan
13:43 subcutaneous the SC this one is going
13:45 directly by needle under your skin but
13:47 as you can imagine not many patients
13:49 want to go that route every time they
13:51 have a migraine uh you know there’s a
13:54 significant delay between the the time
13:56 to T-Max which is the peak levels in
13:58 your blood so really cambia represents
14:00 an option to treat early those headaches
14:03 where you wake up with them from sleep
14:04 or they’re really fast onset or you just
14:06 need immediately
14:08 so uh these are kind of the the
14:11 indications which would be fast acting
14:13 attacks president Awakening or if you
14:15 have early nausea photosensitivity or a
14:18 thing for that
14:20 so there was a impact study which was
14:22 kind of their pivotal trial they
14:24 included adult patients with a history
14:26 of migraine weight or without Aura and
14:28 they only really excluded those who are
14:30 unable to perform the whole protocol or
14:32 were completely debilitated during their
14:34 heads which would render them unable to
14:36 actually prepare The Gambia
14:38 um so they treated one moderate or
14:40 severe attack and then 807 uh points
14:43 were captured in this and their primary
14:45 endpoint was to look at the number or
14:46 percentage of people at two hours if
14:48 you’re saying you know I’ve got no pain
14:49 no nausea no photophobia
14:51 so at two hours uh pain Freedom happened
14:54 in roughly a quarter of patients
14:56 compared to 10 with placebo
14:59 just to give you a relative uh you know
15:01 you can’t really compare apples to
15:03 oranges but in a similar meta-analysis
15:05 of trypten uh you know perhaps they were
15:08 paying free at two hours 29
15:12 for nausea light and Sound Sensitivity
15:14 looking at the freedom of this at two
15:16 hours cambia showed significant
15:18 statistical and clinical improvements
15:20 compared to placebo
15:23 looking at the Adverse Events that they
15:25 encountered in this trial
15:27 um you know there were not a lot of
15:29 significant divergences from Placebo
15:31 maybe a little bit of extra vomiting or
15:34 nausea and apart from that like it
15:37 wasn’t really a well tolerated or poorly
15:40 tolerated from a dyspepsia perspective
15:42 which is what sometimes you’ll hear
15:43 people say that it causes some stomach
15:45 irritation
15:46 so from the Canadian Headache Society it
15:49 recommends cambia offers a rapid onset
15:51 of action as early as 15 minutes and
15:54 that it should be considered as the
15:55 First Choice prescription for the acute
15:57 treatment of migraine attacks of all
15:58 severities the main issue here is the
16:00 cost because sometimes it is difficult
16:02 uh to get it covered and it may be eight
16:05 to ten dollars per dose
16:07 sometimes even with a good answer like
16:10 Gambia it just isn’t enough to treat
16:11 your migraines and you need to use more
16:13 than one mechanism
16:15 so that’s where Steve X comes in we had
16:18 already talked a little bit earlier
16:19 about combining your medicines and so
16:22 this formulation contains both
16:23 sumatriptan and naproxen but it’s not uh
16:27 the traditional signature than you think
16:28 it’s an RT formulation uh and so it’s
16:31 also co-absorbed with naproxen in such a
16:33 way that they needed to reduce the
16:36 milligrams of it you don’t need the full
16:38 100. so it’s indicated for the acute
16:41 treatment of migraine with or without
16:42 Aura recommended dose is to have one
16:44 tablet and you can repeat it uh two to
16:47 four hours later if you still need to
16:49 maximum for two tabs per day
16:52 so it acts on multiple mechanisms in
16:55 migraine and I think that’s why it’s
16:56 more successful than either agent alone
16:57 so the trip down it prevents or reverses
17:00 the vasodilation which we think of more
17:03 as an epiphenomenon of migraine and not
17:05 the cause of the pain itself it inhibits
17:07 the release of cgrp and other
17:09 inflammatory soup that comes out of the
17:11 trigeminal vascular system during the
17:13 migraine attack
17:14 and it also helps to prevent Central
17:16 sensitization and inhibits the way that
17:19 we process and transmit pain in the
17:20 brainstorm
17:21 and naproxen on the other hand IT
17:23 addresses a peripheral mechanisms of
17:25 nervous sensitization uh by you know
17:28 inhibiting uh prostaglandinophen system
17:30 and creating an anti-inflammatory effect
17:32 it also prevents uh Central
17:34 sensitization and there’s evidence that
17:36 over time it may even reverse some of
17:38 that coming out of other pain literature
17:40 so it really is a unique uh formulation
17:44 because it disintegrates very quickly
17:45 and disperses and it’s able to kind of
17:48 get around the slowing of the gut that
17:50 occurs from migraine and that’s actually
17:52 we think the basis of the nausea that
17:53 many experience
17:56 so looking at some pivotal trials for
17:58 this one
17:59 there are actually two that they
18:01 repeated uh to be doubly sure and uh
18:04 they were primarily looking at pain
18:06 relief at two hours and so these were
18:09 placebo-controlled single attack studies
18:11 and uh so they were also allowed to take
18:14 rescue medication anytime two hours post
18:16 study drug uh just so that they weren’t
18:18 you know torturing them during this
18:20 trial but many did not need to so
18:23 compared to Placebo subox also achieved
18:25 significant decreases in light and Sound
18:27 Sensitivity and nausea two hours after
18:29 dosing
18:30 looking at the Adverse Events there were
18:33 no new safety findings for subex
18:35 compared to each individual component
18:37 alone so nothing new from this
18:39 formulation that makes you think it’s
18:40 more dangerous than either sumatrist or
18:43 an approximate loan
18:45 so in summary about Steve X It’s a
18:48 combination Superior to either medicine
18:49 given a loan if you put them together
18:51 the size of the effect is greater than
18:53 either agent and and that’s why I want
18:55 to hammer this home for you early
18:58 intervention results are improved for
18:59 both two hours and 2 to 24 hour
19:01 pain-free response onset of action about
19:04 30 minutes so a little slower than
19:05 cambia but still a good effect size and
19:08 it has reliable two-hour and sustained
19:10 pain-free response and so many people
19:13 did not need to take a second dose of
19:15 anything
19:16 most of those who are paying for two
19:18 hours remain pain-free at 24 hours so
19:20 for those of you who are concerned about
19:22 rebound you know like oh I’m gonna feel
19:23 fine tonight and I’m going to wake up
19:25 again with this migraine um you know
19:27 this medication tends to avoid that and
19:30 it may enhance patient compliance
19:31 because like I mentioned I mean I don’t
19:34 blame my patients most of them don’t
19:35 want to take extra medicine if they
19:37 don’t have to and so some may not feel
19:39 comfortable combining it even when you
19:41 know we give them reassurance
19:44 the next one I want to talk to you about
19:46 are the timel drops and this one is kind
19:48 of like an under the radar you know
19:50 those in the know kind of are gaining
19:52 traction uh with this idea so use
19:56 timelineate 0.5 percent and you put one
19:59 drop in each eye right at the onset of
20:02 migraine and then you can do it again 30
20:04 minutes later this came out of a really
20:06 fascinating observation it was an
20:08 ophthalmologist and his friend who also
20:10 treat migraines and they were talking
20:11 about helping their daughter and they
20:13 had observed some cases where in
20:14 treating glaucoma with these drops
20:16 patients reported a lot of improvement
20:18 in their migraines and then we get into
20:20 like well is this really a migraine or
20:22 is it a glaucoma attack who knows but uh
20:25 there’s a lot of good rationale why this
20:27 makes sense so oral timel the pill is
20:31 FDA approved for migraine prophylaxis
20:33 they’ve done the trials on it and it
20:34 works like Propranolol or metoprolol or
20:36 other ones from the same family
20:38 the issue with the oral is that it’s
20:40 kind of gradually absorbed through the
20:42 stomach like the other medicines and
20:43 first pass metabolism so when you drain
20:46 the whole bowel and stomach as it
20:48 absorbs food it all goes through the
20:50 liver first and you’re going to lose a
20:52 portion of that drug before it even gets
20:54 back to the circulation so you’re kind
20:56 of taking a little tax there
20:58 the ophthalmic drops on the other hand
21:00 it bypasses that directly into the
21:02 systemic circulation by being absorbed
21:04 through cornea and the blood vessels of
21:05 the eye so it also goes in through
21:07 lacrimal duct into the nasopharyngeal
21:09 mucosa into a lesser extent it’s
21:11 absorbed through the the conjunctival
21:13 epithelium around your eye and into the
21:16 GI tract from there
21:17 the maximum plasma concentration Peaks
21:20 within 10 to 15 minutes so very rapid
21:22 onset and what’s interesting is that one
21:24 drop of this results in a plasma
21:27 concentration of two nanograms per ml
21:29 within that time frame and it blocks
21:32 beta 1 and beta 2 receptors about 80
21:34 with that plasma concentration so
21:37 significant therapeutic serum amounts
21:40 can enter the bloodstream Through The
21:42 Eyes so this is a very interesting
21:44 finding
21:46 so we have a randomized crossover
21:48 placebo-controlled pilot study they were
21:51 looking at timelo eyedrop there’s no
21:52 Board of treatment for migraine and
21:54 participants were recruited out of
21:55 Kansas City neurology and Ophthalmology
21:57 clinics they also posted some flyers
21:59 around the Hospitals and Clinics they
22:01 included any men or women over 18 who
22:03 had a good diagnosis of migraine by ic83
22:06 and then they gave them screening neuro
22:09 and eye exams
22:10 these people who passed the screening
22:12 were then randomized one to one to
22:14 either get uh timolol eye drops as we
22:17 mentioned with that dose or artificial
22:19 tears which are just saline and they
22:21 were doing one drop in both eyes stood
22:23 on that and 30 minutes after
22:25 the participants were followed for five
22:27 visits over four months so each a month
22:30 between each visit and crossed over at
22:32 the two-month Mark so at that point
22:34 they’re given a three-day washout period
22:35 where they take no drops and then they
22:37 switch over and they still don’t know
22:39 they’re blinded at this point
22:41 the participants rated their migraine
22:43 attacks on a scale of zero to three in
22:44 terms of severity and at the end of the
22:46 study they were asked to rate the
22:48 effectiveness of their drops on a scale
22:50 of one to four
22:53 so in the course of the study almost 200
22:57 separate migraine attacks were studied
22:59 among 10 different individuals and they
23:01 rated the effectiveness timilal as 2.4
23:04 as opposed to Placebo 1.4 four
23:07 participants with 10 mL found it highly
23:09 effective compared to Placebo and one
23:12 founded the other way they thought the
23:13 placebo was much more effective
23:15 uh the average percentage of headaches
23:17 with the severity of none or mile to two
23:19 hours timel was 78 versus placebo 57 and
23:23 you may be saying well look at the size
23:25 of these Placebo responses what I would
23:27 say is that pain is extremely
23:28 psychological and expectation really
23:30 does affect and if you look at any of
23:32 our trials in migraine or other pain
23:34 niches throughout the literature Placebo
23:37 response can be quite significant and so
23:39 I think sometimes people feel like
23:41 Placebo means fake or it’s not true but
23:43 it’s a very valid and useful therapeutic
23:47 tool and I think we have to respect the
23:49 size for us to prove that a drug is
23:52 useful you just have to prove that it is
23:53 in excess of the placebo
23:55 and I think uh we’re starting to see
23:58 some evidence here for timelo uh
24:00 although the quality of this trial is
24:01 limited by you know size and statistical
24:04 significance so they did some statistics
24:07 to determine the validity of this
24:08 finding and they uh wanted to account
24:11 for repeated measurements across them
24:13 the difference in this trial was not
24:14 found to be significant so we have these
24:17 cutoffs of p-values which determine
24:19 whether or not the probability of a
24:21 finding is attributed to chance alone
24:23 um and really the limitation of this is
24:26 the sample size if we can do a very
24:27 large perspective controlled trial of
24:29 this uh this may be able to demonstrate
24:32 the signal but I will tell you those who
24:34 use these drops think like they swear by
24:36 them and they seem to be quite useful
24:38 what’s nice is that you know when we’re
24:41 taking this approach we would say well
24:42 we got to balance the risks and the
24:43 benefits uh Adverse Events one person
24:47 had a branch retinal artery occlusion uh
24:49 which is a type of stroke in the back of
24:51 the eye and it was taking Placebo so
24:54 it’s really thought not to be related to
24:55 the trial
24:56 no real other Adverse Events including
24:59 low blood pressure or slow heart were
25:01 observed during the trial
25:04 so in summary you can use these 0.5
25:06 drops one drop in each eye at the onset
25:09 of migraine and 30 minutes later
25:10 generally well tolerated with few side
25:13 effects even with daily use
25:15 however they’re not tolerated by
25:17 everyone and this goes back to Alex’s
25:20 warning about talking to your family
25:22 doctor to see if it’s appropriate for
25:23 you
25:24 um some beta blockers can lower your
25:26 blood pressure slow the heart rate very
25:28 rarely they may have an adverse effect
25:30 on asthma or reactive airway disease and
25:33 in diabetics if you’re prone to
25:34 hypoglycemia the low blood sugar it can
25:37 mask the symptoms of this and they can
25:39 lead you to trouble so it’s important to
25:40 see with your Healthcare team if it’s
25:42 appropriate for you
25:44 next we’re going to jump to the
25:46 pregnancy World
25:48 um you know I think many women are
25:50 rightfully concerned about taking
25:51 medicines during conception pregnancy
25:54 and lactation it’s a scary time and
25:56 you’re making a really big investment in
25:58 bringing a new world a new life into the
26:00 world you want to give them the best
26:02 chance they have and for some women that
26:04 means they’re willing to sacrifice all
26:05 of their comfort and so I would say it
26:08 doesn’t have to be that way
26:10 you know the purists want to stop all
26:11 medicines except for their vitamins
26:14 um but I would say many things have
26:16 demonstrated significant safety and
26:18 tolerability for migraine uh treatment
26:20 paracetamol or Tylenol acetaminophen is
26:23 probably the safest medication
26:25 throughout pregnancy it’s considered
26:27 safe across all phases
26:29 well sumatriptan I would say most of us
26:33 feel that enough safety data has
26:34 accumulated through database research
26:36 looking at those who you know didn’t
26:38 know they were pregnant or were in such
26:40 Dire Straits that they took it anyway
26:42 and there doesn’t seem to be a
26:44 significant safety concern
26:46 other medications I just want to
26:48 highlight are NSAIDs they are generally
26:51 compatible with lactation breastfeeding
26:53 but really I would avoid them even
26:55 though they say okay yeah perhaps it
26:57 could be used very specifically in the
26:58 second trimester I generally advise all
27:01 women to stop NSAIDs during their
27:03 pregnancy it carries a small risk of
27:05 closing a little Channel across the
27:07 heart that the baby uses to breathe
27:09 while it’s in the amnion the fluid and
27:12 this is so important because if you fuse
27:14 it prematurely the baby will suffocate
27:17 and die in the womb so it is critical to
27:19 avoid these medications
27:22 so I came here
27:24 I would say first line treatments for
27:26 migraine are usually non-pharmacological
27:29 and this means working on your sleep
27:31 hygiene doing good light exercises
27:33 tolerated nutritious meals adequate
27:36 hydration and other formats that work
27:39 are you know biofeedback relaxation
27:41 training like deep breathing and body
27:42 scanning
27:44 the preferred acute treatment is when we
27:46 do have to use them would be things like
27:47 Tylenol gravel or diphenhydramine and
27:51 metaclopramide macro
27:53 Tylenol is really the safest option if
27:56 you want to just stick to the The Bare
27:58 Bones but sumatriptan is probably safe
28:00 during pregnancy based on our
28:01 accumulated data
28:03 Advil and other answers like I mentioned
28:05 are to be avoided
28:07 so let’s go quickly over the sumatriptan
28:10 nortriptanatrex pregnancy uh registry
28:12 Trek The Met is actually the American
28:14 name for suevex
28:16 and this was important uh to see
28:19 long-term safety surveillance data and
28:22 kind of give us our initial index of
28:24 safety and what I found was that no
28:27 evidence of turmotogenicity from
28:28 pre-clinical studies of sumotropin or
28:31 narrow trippin were reported so this was
28:32 the basis uh to to start this registry
28:35 and sumatriptan has been assigned
28:38 pregnancy category C
28:41 in this study uh this registry we had a
28:44 626 pregnancy outcomes obtained from 617
28:48 pregnancies so some of them obviously
28:50 had more than one child related and in
28:53 the first trimester there were 528
28:54 exposures
28:56 474 live-borne infants 34 spontaneous
28:59 losses 15 induced abortions five still
29:03 of births of the kids that were born
29:05 there were 20 birth defects uh in total
29:08 16 live born in for infants one
29:11 stillborn
29:12 and three induced abortions
29:14 so for an average of birth defect of
29:17 about 4.2 percent with a confidence
29:19 interval you know based on our
29:21 statistical analysis of 2.6 to 6.5
29:23 percent
29:24 uh in the second trimester there were 78
29:26 three infants of birth defects
29:29 uh and in the third trimester oh dear
29:33 kind of went out of order here but what
29:35 I wanted to show you here is that uh
29:37 birth defects of any trimester of
29:38 exposure are about 4.2 percent on
29:40 average and if you compare this uh with
29:43 the general population we have good
29:44 estimates of this and we think that in
29:47 the United States in particular uh about
29:50 one in every 33 children or about three
29:53 percent uh is born with a birth defect
29:55 and this Falls well within the range of
29:57 that confidence interval and after a
29:59 thorough statistical analysis they did
30:01 not think that um any increased risk of
30:04 congenital defect was observed
30:06 however what I want to stress is that
30:08 observational databases like these are
30:10 insufficient to be conclusive and so
30:13 really with limited data on the second
30:15 and third trimesters it really is a
30:17 conversation that you have to have with
30:18 each person and really weigh the risks
30:21 and benefits and and what they’re
30:22 willing to accept so I would say it
30:24 should only be given during pregnancy
30:26 when the benefit outweighs arises
30:29 we also have a cohort study here looking
30:31 at pregnancy outcomes after tryptin use
30:34 and this is a prospective observational
30:36 cohort study
30:40 and uh what I wanted to highlight here
30:42 was actually sorry I think we lost uh or
30:44 cut off our thing here but basically it
30:47 said the same thing that no significant
30:49 safety risk in terms of abortion or uh
30:52 spontaneous fatal defects was observed
30:56 next we’re going to talk about the
30:57 cardiovascular risk factors
30:59 um just to recap that this is not an
31:02 exhaustive list by any means but I want
31:03 to list the most common
31:05 contraindications for why you would not
31:06 take these drugs uh for NSAIDs
31:09 especially if you’re on anticoagulants
31:10 like any of the warfarin or the newer
31:13 ones like Xarelto or the 10A Inhibitors
31:16 you’re going to want to avoid these
31:17 because they increase the risk of a
31:19 fatal bleeding event or a serious
31:21 bleeding event whether it’s into your
31:22 bowel or into your head or elsewhere
31:25 if you’ve had bariatric surgery where
31:27 they do like a ruin y Bypass or some
31:30 other type of procedure like that an
31:32 anastomosis you may be at risk for
31:34 significant complications if you
31:36 continue to take infants and so many
31:37 people are forbidden from that
31:39 other people include different types of
31:42 ulcerative or inflammatory disease
31:43 whether it’s peptic ulcers IBD like
31:45 Crohn’s or ulcerative colitis and also
31:48 significant kidney disease as NSAIDs of
31:50 prolonged use can cause kidney damage
31:52 for the trip dance we’ve already covered
31:54 it a couple times here but I’ll recap in
31:56 brief coronary artery disease stroke or
31:59 mini stroke vascular disease including
32:02 uncontrolled high blood pressure
32:03 Reynolds phenomenon and more and there’s
32:06 an unfortunate group of people that fall
32:08 in the Venn diagram of this and you know
32:11 for many of them they feel very
32:12 disheartened because they walk away from
32:14 the doctor and they’re saying well you
32:15 know what all I’ve got for you is
32:16 Tylenol so good luck to you and that I
32:20 think is the wrong message because
32:21 there’s so much more that you can offer
32:23 them
32:24 so what can be used well of course there
32:27 is Tylenol
32:28 um for many of them aspirin is an option
32:31 unless you’re on a blood thinner
32:33 lismetidan was a medicine that we were
32:35 really hoping to see in Canada and it’s
32:37 the cousin of the trip dance called the
32:39 guy 10 and this one acts on a slightly
32:42 different serotonin receptor thought Not
32:44 to cause vasoconstriction and it was
32:46 going to be safe for use in these
32:48 patients however at the last minute
32:50 Health Canada pulled approval because
32:52 they couldn’t agree on the labeling and
32:53 the manufacturer would Drew their
32:55 application
32:56 other options include non-invasive nerve
32:59 stimulators the cephaly and the gamma
33:01 core which I spoke about in a different
33:02 talk for migraine Canada and we’ll lead
33:04 you there uh into the comments below
33:07 and uh the issue with those is that you
33:10 cannot use if you have any other
33:11 implanted devices so you know that if
33:13 you have a pacemaker or something you’re
33:14 kind of forbidden from them
33:16 gpents which we’ll get to in a second or
33:19 a new class of acute medication that
33:21 perhaps don’t cause medication over his
33:22 headache and may be also safe to use in
33:25 those with cardiovascular risk and we
33:27 talked about timel eye drops which could
33:29 be good but also have to be used in
33:30 caution if you have significant cardiac
33:33 disease
33:35 next up are the elderly uh you know I
33:39 think there are many people who are
33:40 Little White Knuckles with the trip
33:41 dance because the original trials did
33:43 not include people over 65. uh and this
33:46 is a problem I mean most of these people
33:48 who have migraines a particular
33:49 population uh it continues on uh as they
33:53 go through life and so I would say for
33:55 elders what I counsel them is that
33:57 naproximate hydroxyzine are the most
33:59 commonly used for for individuals with
34:02 migraine retention and certain rescue
34:04 medicines that we normally consider for
34:06 migraine like triptans and the younger
34:08 have to be used with more caution
34:10 because over time you accrue more
34:11 vascular risk factors and there’s a
34:13 significant risk of of stroke or
34:15 coronary disease
34:17 like I mentioned there’s a lack of
34:18 robust data beyond the age of 65 but it
34:20 has accrued you know in the same way
34:22 that we got those pregnancy databases
34:25 what’s important to note is that as you
34:26 get older your arteries Harden you
34:28 develop Trace diabetes and hypertension
34:31 cholesterol all these things and the
34:33 risk of these events increases over time
34:35 so it’s important to not just write a
34:37 prescription for three years and walk
34:39 away every time you go see your family
34:40 doctor it’s prudent once a year to
34:42 review all over your masses
34:44 absent any significant risk factors you
34:47 know I’m usually pretty safe to to
34:50 prescribe these for elders I look in my
34:52 practice and I think okay well I have a
34:54 500 pound OB 33 year old who doesn’t
34:56 walk and smoke every day uh and then I
35:00 have you know an elder who runs for two
35:02 hours every day and is 92 but you know
35:04 it’s a bit of the fiddle I think I would
35:06 have more compunction about you know
35:09 prescribing a trip then for the first
35:10 individual as opposed to this elder so I
35:13 think we have to think less about
35:14 chronological age look at physiologic
35:17 age and then the whole clinical picture
35:20 so risk for ischemic stroke and coronary
35:24 heart disease associated with migraine
35:25 and migraine medication among older
35:27 adults this was an interesting study
35:29 analyzing over 35
35:31 000 Medicare beneficiaries through their
35:33 EMR
35:35 and what they did was they found about
35:37 22 000 who had no history of
35:39 cardiovascular disease and matched them
35:42 to age controls uh about 87 88 000 who
35:46 did not have migraine or cardiovascular
35:48 disease then they took a second arm and
35:51 they took about 16 000 with a history of
35:54 cardiovascular disease and migraine and
35:56 they matched them to uh 63 000 patients
35:59 without migraine but with cardiovascular
36:01 disease
36:02 so the patients with a history of
36:05 migraine taking a trip and had a lower
36:06 risk for
36:07 um you know coronary heart disease
36:09 events versus those without a history of
36:12 migraine so in fact it was perhaps
36:13 protective there was also no evidence of
36:16 a difference in the risk of ischemic
36:18 stroke compared to match controls so you
36:20 know really it seems like it was safe in
36:22 this group the events occurred of course
36:24 but when you compare it to a large
36:26 cohort of people of the same age
36:28 relatively matched for their history of
36:30 cardiac health uh there wasn’t an
36:32 increased signal
36:35 other devices that you could consider
36:37 and this goes back to that talk I gave
36:38 previously with migraine Canada would be
36:40 the gamma core or the cephaly these are
36:43 the two that are available in Canada and
36:44 then you don’t have time to go into
36:45 detail today but you can see it in our
36:47 other talk unfortunately the inora and
36:49 the neurodio are not available in Canada
36:51 at present and I don’t think there are
36:53 plans to do
36:56 so next up on our agenda is the gpans
37:00 so you know we’re joking amongst
37:02 ourselves like I don’t know how people
37:04 name these medicines I think somewhere
37:06 they’ve changed a poor intern in the
37:08 basement they’re throwing down Scrabble
37:09 tiles to the name is new metaphors so
37:12 what is a gpent it is a small molecule
37:15 calcitonin Gene related peptide receptor
37:17 antagonist so that’s a mouthful
37:19 basically if you’re familiar with the
37:21 monocle antibodies cgrp is a chemical
37:24 secreted from nerve endings that is
37:26 pro-inflammatory and it perpetuates that
37:28 vicious migraine cycle if you can block
37:31 it either the molecule or the keyhole
37:33 that it fits into the receptor you have
37:35 a good chance of reducing migraines so
37:38 this one is an oral as opposed to the
37:40 injected antibodies and when we think
37:43 about how cgrp plays a role in migraine
37:45 blocking it seems to block the
37:48 neurogenic inflammation it decreases the
37:50 dilatation of arteries and it inhibits
37:52 pain transmission I mean this is kind of
37:54 a simplistic overview but I think it’s a
37:56 really good place to start
37:58 so what is cgrp it’s a really large
38:01 neuropeptide and it is the most abundant
38:03 one in the trigeminal ganglion it’s
38:05 located in both CNA Delta nerve fibers
38:09 and it gets released with glutamate
38:11 whenever you activate that trigeminal
38:13 gangla the trigeminal ganglion and the
38:15 trigeminal cervical complex is the area
38:17 through the brain stem that we think not
38:20 generates the migraine perhaps but is
38:21 the main Highway through which we
38:23 transmit and process pain for migraines
38:25 and so it has a lot of different
38:28 functions all over the body but luckily
38:30 most of these are in parallel so it’s a
38:32 redundant molecule and blocking it
38:34 doesn’t seem to cause many side effects
38:35 except in migraine where it turns it off
38:39 so how did we start to think about this
38:42 as a potential Target even
38:44 um you know there was a couple really
38:46 smart people who made some interesting
38:48 observations about cgrp back in the 80s
38:51 and they noticed that levels in the
38:53 blood were raised during a migraine and
38:55 these dropped when you gave them
38:56 sumotriptan
38:58 in migrants when they were in that Pro
39:00 monetary phase where the headache is
39:01 coming on cgrp was up and compared to
39:04 when you look at just the intraectal
39:05 part where they have no headache
39:08 interestingly I don’t know how they got
39:10 ethics approval to do this they took
39:11 healthy controls with no migraine and
39:13 Infused large quantities of cgrp
39:15 intravenously and this was able to
39:17 Target you know a significant headache
39:21 we also noted that there’s increased
39:23 levels of cgrp in chronic migraines as
39:25 composed compared to episodic migrainers
39:28 and even higher than those controls who
39:31 had no headaches so it seems to be dose
39:32 dependent
39:33 also another researcher realized that oh
39:36 increased levels of cgrp predicts
39:38 response to Botox so all of this
39:40 evidence started occurring and people
39:41 thought well what happens if we block it
39:44 so here come the new cjrp antagonist
39:48 that you can take orally
39:49 poised to come to Canada hopefully soon
39:51 we’ll have a bro Japan somewhere between
39:53 November to January and then we will see
39:56 arrival of a togapentin or imagine that
39:58 and they’re all slightly different but I
39:59 highlighted a couple things here
40:01 I told Japan can be used as prevention
40:03 for both episodic and chronic migraines
40:06 ubro Japan is approved for acute
40:08 treatment and remember Japan can be used
40:11 for acute treatment or prevention of
40:12 episodic and chronic migraine so it’s
40:15 really kind of blurring the Paradigm
40:16 that we talked about those two broad
40:18 Strokes of treatment acute and
40:19 preventive they all are at receptor
40:22 antagonists they all are taken orally
40:25 and they’re manufactured by various
40:26 companies
40:29 most importantly they do not cause
40:31 vasoconstriction like the tryptins
40:33 there’s no contradictations for youth
40:35 with patients with vascular disease and
40:37 thankfully during the trials no one
40:39 observed any serous vascular events
40:41 also important to highlight is that
40:43 they’re not thought to contribute to
40:44 medication ovary’s headache so this is a
40:47 good option to give to patients who are
40:49 currently overusing their acute
40:50 strategies without blaming them
40:52 another option is that this is good for
40:55 the needle phobic the patients who
40:56 really don’t want to administer a needle
40:58 and the thought of that is just
40:59 terrifying to them
41:01 when should we be considering these for
41:03 use I think for me uh anyone 18 year
41:06 older with a confirmed migraine
41:08 diagnosis they have failed to respond to
41:10 either endsets or triptans or they are
41:13 contraindicated because of the various
41:15 medical conditions
41:17 uh for the sake of time today I’m just
41:19 going to present the data from these
41:21 molecules in aggregate
41:22 but you know it’s important to note you
41:24 can never really make head-to-head
41:25 comparisons of these trials uh just
41:27 because uh you know they’re all slightly
41:29 different in the way they design them
41:31 they measure the outcome and so it
41:33 really isn’t fair to put them all
41:34 together
41:36 uh quickly about Uber Japan it’s an
41:39 acute treatment you take 50 or 100
41:40 milligrams as needed and you can take a
41:43 second dose at least two hours later the
41:45 maximum dose for 24 hours is 200
41:47 milligrams and if you have hepatic or
41:49 renal impairment you’re going to want to
41:51 adjust the dose to 50 milligrams
41:54 it’s well tolerated with side effects
41:56 similar to Placebo the most common
41:58 effects were nausea and dizziness and if
42:01 you’re in the know about the research
42:02 for these molecules the very first one
42:04 that came up calcipam did have some
42:06 fatal fatal liver hepatoxicity and
42:08 elevations they tweak these molecules
42:11 and they are particularly safe and no
42:13 significant liver signal was seen in the
42:16 latest iterations
42:18 on the other hand is another medication
42:21 safety of the more than 18 doses in a
42:24 30-day period is not established and
42:26 this is interesting because you can take
42:29 it every other day as a preventive
42:31 okay and then you top it up as needed on
42:34 the days that you don’t take it so it’s
42:35 a little bit of a confusing algorithm
42:37 and they’re actually repeating the
42:39 trials looking at Daily doses to get rid
42:41 of that
42:43 um contraindications for this would just
42:44 be hypersensitivity like an allergy to a
42:46 medication which is the same for any
42:48 medicine and the safety profile was
42:50 comparable to all the other cgrp
42:52 antagonist trials
42:55 so looking at the data these are the
42:58 major pivotal trials for ubo Japan and
43:00 romanticipant from an acute perspective
43:01 they were all very very large and well
43:04 designed and they did this to obtain
43:06 good statistical significance which they
43:08 all met their endpoints
43:09 looking at two hour pain Freedom uh you
43:12 can see that the difference versus
43:13 placebo is is is uh I would say
43:16 clinically significant however when
43:19 you’re calculating the number needed to
43:20 treat this is the inverse of the
43:21 difference versus placebo therapeutic
43:23 gain
43:24 um you may need to treat you know
43:26 somewhere between 10 up to 13 instances
43:30 in order to get one good outcome and so
43:34 we’ll talk a little bit more about that
43:36 in a second for two hour most bothersome
43:39 symptom Freedom again there’s some gain
43:42 versus placebo that with the number
43:43 needed to treat ranging somewhere
43:45 between uh you know 8 to 12.
43:49 so how do they measure up to the trip
43:51 dance like is this drug worth your time
43:54 uh there is a comparison of the new
43:55 pharmacologic agent against the trip
43:57 dance a recent Gemma open network
44:00 paper and this included 64 randomized
44:02 controlled trials
44:04 and what it found was that the two-hour
44:06 brain Freedom triptans were Superior to
44:08 GPS with an odds ratio somewhere between
44:10 like 1.5 to 3.4
44:14 pain Freedom or pain relief at two hours
44:16 after the dose Lavita Dan ramangapan and
44:19 a brochure band were associated with
44:20 higher odd ratios of pain Freedom
44:22 compared to Placebo but lower compared
44:24 to tryptins and you can see the values
44:26 here on the left
44:28 comparisons between all the new agents
44:30 themselves were not really uh
44:31 significant
44:33 so you know maybe they aren’t as good as
44:35 tripped ends up front however the lack
44:38 of the cardiovascular risk through these
44:39 new classes may offer an alternative to
44:41 triptans for those who couldn’t take
44:42 them anyway
44:44 if we’re looking to compare uh the
44:47 numbers needed to treat this is a good
44:49 meta-analysis I looked at all the
44:50 triptans as well as the cost efficacy if
44:53 you want to delve deeper and you know so
44:55 maybe frobotripton is comparable to some
44:57 of these neurons it has a higher number
44:59 needed to treat whereas the other
45:02 triptans range somewhere between three
45:04 to four or even up to eight
45:09 so for overtryptin is actually like the
45:12 most costly and I think it has some role
45:15 for use in like perimenstrual
45:16 prophylaxis and things like that
45:18 um but I would say the bang for your
45:20 buck uh maybe looking at uh sumitriptan
45:23 rhizotryptin eletryptin
45:25 and uh
45:27 as a general rule of thumb I think when
45:30 you’re trying to understand the number
45:31 needed to treat like what it means to me
45:33 is that you would need like say the
45:36 number needed to treat is 20. that means
45:38 you would have to treat 20 instances
45:40 using this drug before you have one good
45:43 outcome that is not attributed to
45:44 Placebo or just the natural resolution
45:46 of a migraine so when you’re factoring
45:49 in cost I think you really have to take
45:51 it with a grain of salt and I would say
45:53 that you know a general rule of thumb is
45:55 a number needed to five
45:57 the FDA reviewed like the crude data
45:59 from these trials and calculated uh you
46:01 know these numbers needed to treat for
46:03 Freedom uh for Imagine band uh 75
46:06 milligrams 20 and for upro Japan
46:09 somewhere around 10 to 15.
46:13 the costs have yet to be determined in
46:15 Canada but they are pricey South of the
46:16 Border I mean the typical trend is that
46:18 we do pay much less for our medications
46:20 here but uh you know you can see that a
46:23 month supply is somewhere around a
46:25 thousand dollars American
46:27 um so we’ll have to see
46:29 um the cost of a single tablet of a
46:31 brand name trypton is somewhere between
46:32 13 and 18
46:34 um and then typically the wholesaler
46:36 generic versions are half to three
46:38 quarters cheaper
46:41 a quick shout out to Les mittidan we
46:43 mentioned earlier the the daitan That
46:45 Never Was and uh unfortunately we won’t
46:48 be getting it here in Canada but I
46:50 wanted to include it just because you
46:51 may hear about it through some of the
46:53 American channels it meant all of its
46:55 endpoints as well and the thought was
46:56 that it was safe in those with
46:57 cardiovascular issues and it didn’t
46:59 really have a lot of significant
47:01 cardiovascular Adverse Events just a bit
47:03 of disease
47:05 the problem with this one is that
47:07 because of the sedation or drowsiness
47:08 you’re advised not to drive your car for
47:09 eight hours after taking
47:13 so in summary NSAIDs and tryptins remain
47:15 the Mainstays of acute management
47:18 cambia it offers a faster acting
47:20 answered option
47:22 suvex improves adherence in combining
47:24 the agents and with its Gestalt effect
47:26 you know gives you a bit more efficacy
47:28 than you’d get from either alone
47:30 new migraine treatments have arrived to
47:32 Market and there are many more in the
47:33 works that are coming so I I think that
47:35 should give hope to many migrators
47:37 and the cgrp molecule antagonists are
47:39 effective safe and well tolerated a good
47:42 potential option for those who have
47:44 failed to respond to tryptins are insets
47:46 or are contraindicated for me questions
47:48 remain about the cost Effectiveness and
47:50 access in Canadian markets so with that
47:53 I want to thank you very much for your
47:54 attention and turn the table to some
47:56 questions